These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38689600)

  • 1. Nanomedicine-based disulfiram and metal ion co-delivery strategies for cancer treatment.
    Shen X; Sheng H; Zhang Y; Dong X; Kou L; Yao Q; Zhao X
    Int J Pharm X; 2024 Jun; 7():100248. PubMed ID: 38689600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
    Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
    J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy.
    Qu Y; Li A; Ma L; Iqbal S; Sun X; Ma W; Li C; Zheng D; Xu Z; Zhao Z; Ma D
    Int J Pharm; 2021 Mar; 597():120250. PubMed ID: 33486040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
    Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
    Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy.
    McMahon A; Chen W; Li F
    J Control Release; 2020 Mar; 319():352-359. PubMed ID: 31911155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfiram-loaded copper sulfide nanoparticles for potential anti-glioma therapy.
    Lan QH; Du CC; Yu RJ; Zhai J; Shi Y; Kou L; Xiao J; Lu CT; Zhao YZ; Yao Q
    Int J Pharm; 2021 Sep; 607():120978. PubMed ID: 34371152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer.
    Zhang H; Song F; Dong C; Yu L; Chang C; Chen Y
    J Nanobiotechnology; 2021 Sep; 19(1):290. PubMed ID: 34579711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
    Chen W; Yang W; Chen P; Huang Y; Li F
    ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow.
    Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y
    ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens.
    Lu Y; Pan Q; Gao W; Pu Y; Luo K; He B; Gu Z
    Biomaterials; 2022 Feb; 281():121335. PubMed ID: 34979419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
    Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
    Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the delivery of disulfiram: a critical analysis of promising approaches to improve its pharmacokinetic profile and anticancer efficacy.
    Farooq MA; Aquib M; Khan DH; Hussain Z; Ahsan A; Baig MMFA; Wande DP; Ahmad MM; Ahsan HM; Jiajie J; Wang B
    Daru; 2019 Dec; 27(2):853-862. PubMed ID: 31758497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
    Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
    Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn
    Zhao YZ; Lin MT; Lan QH; Zhai YY; Xu HL; Xiao J; Kou L; Yao Q
    Mol Pharm; 2020 Oct; 17(10):3857-3869. PubMed ID: 32833457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer.
    Chang Y; Jiang J; Chen W; Yang W; Chen L; Chen P; Shen J; Qian S; Zhou T; Wu L; Hong L; Huang Y; Li F
    Appl Mater Today; 2020 Mar; 18():. PubMed ID: 34746366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram: A Food and Drug Administration-approved multifunctional role in synergistically drug delivery systems for tumor treatment.
    Xu L; Sun Y; Li Y; Sun J; Guo Y; Shen Q; Wei Q; Shen JW
    Int J Pharm; 2022 Oct; 626():122130. PubMed ID: 36007849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of disulfiram and copper for cancer treatment.
    Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W
    Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
    Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
    J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.
    Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B
    Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems.
    Kang X; Jadhav S; Annaji M; Huang CH; Amin R; Shen J; Ashby CR; Tiwari AK; Babu RJ; Chen P
    Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.